Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

Archives of Ophthalmology

Volumn 114, Issue 1, 1996, Pages 66-71

  Adamis, Anthony P ^a,b,d   Shima, David T ^a,b   Tolentino, Michael J ^a,b   Gragoudas, Evangelos S ^a   Ferrara, Napoleone ^c   Folkman, Judah ^b   D'Amore, Patricia A ^a,b   Miller, Joan W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c GENENTECH INC   (United States)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIAZEPAM; GENTAMICIN; KETAMINE; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PENTOBARBITAL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MIXTURE; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; IRIS BLOOD VESSEL; MACACA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA VEIN OCCLUSION; SUBRETINAL NEOVASCULARIZATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030067257     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130062010     Document Type: Article

References (35)

1. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K 1948,68:137-180
2. Ashton N. Retinal vascularization in health and disease Am J Ophthlamol 1957; 44:7-24.
3. Wise GN. Retinal neovascularization Trans Am Ophthalmol Soc. 1956;54:729-826.
4. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35.3974-3978.
5. Shweiki D, Itin A, Soffer O, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359:843-845.
6. Shima DT, Adamis AP, Ferrara N, Allende R, Yeo K, D'Amore PA. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor as the mitogen Mol Med. 1995;2:64-75.
7. Plate KH, Breler G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992, 359:845-848.
8. Miller J, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
9. Adamis AP, Miller J, Bernal M, et al Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
10. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messanger RNA and vascular endothelial growth factor- like activity in proliferate diabetic retinopathy. Arch Ophthalmol. 1994;112: 1476-1482.
11. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients wth diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487
12. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor- induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362: 841-844.
13. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 1994;367:576-579.
14. Virdi PS, Hayreh SS. Ocular neovascularization with retinal vascular occlusion, I: association with experimental vein occlusion Arch Ophthalmol. 1982;100: 331-341.
15. Jiang LQ, Jorquera M, Streilein JW Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci. 1993;34:3347-3354.
16. Nork TM, Tso MO, Duvall J, Hayreh SS. Cellular mechanisms of ins neovascularization secondary to retinal vein occlusion. Arch Ophthalmol. 1989;107: 581-586.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data Biometrics. 1977;33:159-174.
18. Kim KJ, Li B, Houck K, Winer J, Ferrara N The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 1992;7:53-64
19. Maglione D, Guerriero V, Vigliette G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991;88:9267-9271
20. Rothman KJ. Matching. In: Modern Epidemiology. Boston, Mass: Little Brown & Co Inc; 1986:275-279.
21. Frank RN. Vascular endothelial growth factor its role in retinal vascular proliferation. N Engl J Med. 1994;331:1519-1520.
22. Goto F, Goto K, Weindel K, Folkman J Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels Lab Invest. 1993;69.508-517.
23. Pepper MS, Ferrara N, Orci L, Montesano R Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992;189. 824-831.
24. Sivalingam A, Kenney GC, Brown WE, Benson L, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1990;108.869-872
25. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9-14.
26. Miller JW, Stinson WG, Gregory WA, El-Koumy HA, Puliafito CA. Phthalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology. 1991;98 1711-1719.
27. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905-909.
28. Stone J, Itan A, Alon T, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-4747.
29. Simorre-Pinatel V, Guerrin M, Chollet P, et al. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci. 1994;35 3393-3400.
30. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL Comparitive analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995;44:98-103.
31. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J. 1989;8: 3801-3806.
32. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246: 1306-1309.
33. Connolly DT, Hewelman DM, Nelson R, et al Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989; 84:1478-1489.
34. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-670.
35. Tolentino MJ, Miller JW, Gragoudas ES, et al. Vascular endothelial growth factor is sufficient to produce ocular neovascularization in a non-human primate. Invest Ophthalmol Vis Sci. 1995,36(suppl):1869